Viatris (VTRS) Prepaid Assets (2019 - 2026)
Viatris (VTRS) posted Prepaid Assets of $2.1 billion for Q2 2026, little changed on a QoQ basis from $2.1 billion in Q1 2026, and up 25.15% year-over-year from $1.7 billion in Q2 2025.
Analysis
Viatris (VTRS) Prepaid Assets (2019 - 2026) Analysis & Trends
Viatris has reported Prepaid Assets for 8 years, with the latest figure at $2.1 billion in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 25.15% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 25.15% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 16.03% from the prior year.
- Prepaid Assets was $2.1 billion for Q2 2026 at Viatris, roughly flat from $2.1 billion in the prior quarter.
- The five-year high for Prepaid Assets was $2.1 billion in Q2 2026, with the low at $1.4 billion in Q4 2025.
- Average Prepaid Assets over 5 years is $1.8 billion, with a median of $1.7 billion recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: Prepaid Assets decreased 19.96% in 2022, then rose 28.2% in 2026.
- Over 5 years, Prepaid Assets stood at $1.8 billion in 2022, then grew by 11.98% to $2.0 billion in 2023, then retreated by 15.66% to $1.7 billion in 2024, then slipped by 16.03% to $1.4 billion in 2025, then soared by 46.89% to $2.1 billion in 2026.
- The last three Prepaid Assets figures came in at $2.1 billion (Q2 2026), $2.1 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Bn |
| Mar 31, 2026 | 2.11 Bn |
| Dec 31, 2025 | 1.44 Bn |
| Sep 30, 2025 | 1.49 Bn |
| Jun 30, 2025 | 1.69 Bn |
| Mar 31, 2025 | 1.65 Bn |
| Dec 31, 2024 | 1.71 Bn |
| Sep 30, 2024 | 1.63 Bn |
| Jun 30, 2024 | 1.76 Bn |
| Mar 31, 2024 | 1.93 Bn |
| Dec 31, 2023 | 2.03 Bn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | 1.73 Bn |
| Mar 31, 2023 | 1.76 Bn |
| Dec 31, 2022 | 1.81 Bn |
| Sep 30, 2022 | 1.70 Bn |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 1.76 Bn |
| Dec 31, 2021 | 1.96 Bn |
| Sep 30, 2021 | 2.12 Bn |